TY - JOUR AU - Villa-Morales, María AU - Pérez-Gómez, Laura AU - Pérez Gómez, Eduardo AU - López-Nieva, Pilar AU - Fernández-Navarro, Pablo AU - Santos, Javier PY - 2023 DO - 10.3390/ijms241210350 SN - 1422-0067 UR - https://hdl.handle.net/20.500.14352/104813 T2 - International Journal of Molecular Sciences AB - The standard-of-care treatment of T-cell acute lymphoblastic leukaemia (T-ALL) with chemotherapy usually achieves reasonable rates of initial complete response. However, patients who relapse or do not respond to conventional therapy show... LA - eng M2 - 10350 PB - MDPI KW - T-cell acute lymphoblastic leukaemia (T-ALL) KW - NRF2 (nuclear factor erythroid 2-related factor 2) KW - prognostic biomarker TI - Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia TY - journal article VL - 14 ER -